Add It Up
Immunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.
Progress Against Cancer
Immunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.
A nationwide survey found strong support for complementary therapies like massage and meditation, but also significant barriers to access.
Immunotherapies are poised to change care in advanced endometrial cancer, and more news selected by the editors of Cancer Today.
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals. Among this month’s highlights are an analysis of the racial/ethnic and sex-related differences in genomic...
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We all need hobbies, right?” he says with a grin.) Inside the lab, he uses a...
Physicians consider which patients are ideal for immunotherapy drug combinations.
Protein signatures in the blood could help guide physicians in choosing among different immunotherapy drugs.
Study results show stereotactic body radiation therapy could be added to standard care.
Theranostics offers the promise of combining diagnosis and treatment.
A small study finds no cancer recurrences after two years in patients who skipped breast surgery following a complete response to chemotherapy—but experts say the research is in its very early stages.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More